AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+6.7%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$591M
AUM Growth
+$591M
(+52%)
Cap. Flow
+$160M
Cap. Flow
% of AUM
27.11%
Top 10 Holdings %
Top 10 Hldgs %
38.49%
Holding
69
New
23
Increased
18
Reduced
11
Closed
11
Top Buys
| 1 |
Assertio
ASRT
|
$26.1M |
| 2 |
Energizer
ENR
|
$16.8M |
| 3 |
PLYA
Playa Hotels & Resorts
PLYA
|
$14.9M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$13.9M |
| 5 |
GCI
Gannett Co., Inc
GCI
|
$13.4M |
Top Sells
| 1 |
KATE
Kate Spade & Company
KATE
|
$13.3M |
| 2 |
Deckers Outdoor
DECK
|
$10.3M |
| 3 |
ATRS
Antares Pharma, Inc.
ATRS
|
$9.66M |
| 4 |
VSTO
Vista Outdoor Inc.
VSTO
|
$9.27M |
| 5 |
Boston Beer
SAM
|
$7.81M |
Sector Composition
| 1 | Healthcare | 42.04% |
| 2 | Consumer Discretionary | 29.19% |
| 3 | Consumer Staples | 15.04% |
| 4 | Industrials | 4.63% |
| 5 | Communication Services | 2.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Vanda Pharmaceuticals
VNDA
$279M
| $33.6M | 4.29% | 2,064,000 +456,000 | +28% | +$7.43M |
|
|
2
Assertio
ASRT
$80.4M
| $26.1M | 3.33% | +2,432,000 | New | +$26.1M |
|
3
Hain Celestial
HAIN
$162M
| $26.1M | 3.32% | 672,000 +264,000 | +65% | +$10.2M |
|
4
Freshpet
FRPT
$2.72B
| $22.1M | 2.82% | 1,332,000 -144,000 | -10% | -$2.39M |
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $21.6M | 2.75% | 44,000 +4,000 | +10% | +$1.96M |
|
6
Nomad Foods
NOMD
$2.33B
| $20.5M | 2.62% | 1,456,000 +332,000 | +30% | +$4.68M |
|
|
ADMS
7
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $20.3M | 2.58% | 1,158,000 +294,000 | +34% | +$5.14M |
|
8
Polaris
PII
$3.18B
| $19.9M | 2.54% | 216,000 +84,000 | +64% | +$7.75M |
|
|
SGI
9
Somnigroup International Inc.
SGI
$17.6B
| $18.7M | 2.38% | 350,000 +54,000 | +18% | +$2.88M |
|
|
ATRS
10
DELISTED
Antares Pharma, Inc.
ATRS
| $18.4M | 2.34% | 5,700,000 -3,000,000 | -34% | -$9.66M |
|
|
NVLN
11
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $17.1M | 2.18% | 1,852,000 | – | – |
|
|
12
Energizer
ENR
$1.88B
| $16.8M | 2.14% | +350,000 | New | +$16.8M |
|
13
United Parks & Resorts
PRKS
$2.89B
| $16.3M | 2.07% | 1,000,000 +520,000 | +108% | +$8.46M |
|
|
PLYA
14
DELISTED
Playa Hotels & Resorts
PLYA
| $14.9M | 1.9% | +1,250,000 | New | +$14.9M |
|
15
Hanesbrands
HBI
$2.23B
| $13.9M | 1.77% | 600,000 -100,000 | -14% | -$2.32M |
|
|
MNTA
16
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $13.9M | 1.77% | +820,000 | New | +$13.9M |
|
|
GCI
17
DELISTED
Gannett Co., Inc
GCI
| $13.4M | 1.71% | +1,536,000 | New | +$13.4M |
|
|
AVDL
18
Avadel Pharmaceuticals
AVDL
$1.43B
| $12.7M | 1.62% | 1,150,000 +194,000 | +20% | +$2.14M |
|
|
ALXN
19
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $12.2M | 1.55% | 100,000 -6,000 | -6% | -$730K |
|
|
SBBP
20
DELISTED
Strongbridge Biopharma plc.
SBBP
| $12.1M | 1.54% | 1,692,000 +52,000 | +3% | +$372K |
|
|
QVCGA
21
QVC Group, Inc. Series A Common Stock
QVCGA
$69.2M
| $11.5M | 1.46% | +468,000 | New | +$11.5M |
|
22
Best Buy
BBY
$15.6B
| $11.5M | 1.46% | 200,000 +50,000 | +33% | +$2.87M |
|
23
Abercrombie & Fitch
ANF
$4.46B
| $11.2M | 1.43% | 900,000 +450,000 | +100% | +$5.6M |
|
|
BBBY
24
DELISTED
Bed Bath & Beyond Inc
BBBY
| $10.7M | 1.36% | +352,000 | New | +$10.7M |
|
|
FTD
25
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $10.6M | 1.35% | 528,000 +28,000 | +6% | +$560K |
|